This is of particular interest in inflammatory breast cancer, as recent findings from our lab show SUM-149 cells are heavily glycolytic, heavily dependent on glutamine for survival, and SUM-149 metabolism is regulated by RhoC (28). This evidence concerns the gene RHOC and inflammatory breast carcinoma.